Why MusclePharm (MSLP) Stock Is Gaining On Monday

NEW YORK (TheStreet) -- Shares of MusclePharm Corp. (MSLP) are surging 17.09% to $9.25 on Monday after the company reported an increase in net sales and net income for the 2014 first quarter.

The company, which develops, markets and sells athlete-focused nutritional supplements, reported net sales were up, to $50.2 million from $22.6 million during the year ago quarter.

Net income for the 2014 first quarter was $2.7 million, or 23 cents per diluted share, compared with a net loss of $7.4 million, or $1.78 per share for the 2013 first quarter.

Must Read: Warren Buffett's 10 Favorite Growth Stocks 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MSLP Chart MSLP data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Opko Healthcare's Phillip Frost Is a Major Microcap Investor

Why MusclePharm (MSLP) Stock Is Up Today